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PLANT CELLS AND PLANTS EXPRESSING 
CHIMERIC ISOPRENOID SYNTHASES 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application is a divisional of US. Ser. No. 09/134, 
699, ?led Aug. 14, 1998, issued as US. Pat. No. 6,072,045 
Which is a divisional of US. Ser. No. 08/631,341, ?ed Apr. 
12, 1996 issued as US. Pat. No. 5,824,774. 
STATEMENT AS TO FEDERALLY SPONSORED 
RESEARCH 
This invention Was made in part With Government 
funding, and the Government therefore has certain rights in 
the invention. 
BACKGROUND OF THE INVENTION 
This invention relates to modi?ed isoprenoid synthase 
enzymes, their encoding genes, and uses thereof. 
The term isoprenoid is used to refer to a family of 
compounds derived from the isoprene building block. In 
particular, plant isoprenoids comprise a structurally diverse 
group of compounds that can be divided into classes of 
primary and secondary metabolites (FIG. 1). Isoprenoids 
that are primary metabolites include sterols, carotenoids, 
groWth regulators, and the polyprenol substituents of 
dolichols, quinones, and proteins. These compounds are 
essential for membrane integrity, photoprotection, orches 
tration of developmental programs, and anchoring essential 
biochemical functions to speci?c membrane systems, 
respectively. Isoprenoids that are classi?ed as secondary 
metabolites include monoterpenes, sesquiterpenes, and 
diterpenes. These compounds are said to mediate important 
interactions betWeen plants and their environment. For 
example, speci?c terpenoids have been correlated With 
plant-plant (Stevens, In: Isopentoids in Plants, Nes, W. D. 
Fuller, G., and Tsai, L.-S., eds., Marcel Dekker, NeW York, 
pp. 65480, 1984), plant-insect (Gibson and Pickett, Nature 
3021608, 1983), and plant-pathogen interactions (Stoessl et 
al., Phytochemistry 151855, 1976). 
The common denominator for this diverse array of com 
pounds is their universal ?ve-carbon building block, iso 
prene. The “biogenic isoprene rule” Was employed to ratio 
nalize the biosynthetic origins of all terpenoids derived from 
isoprene (Ruzicka, Experientia 10:357, 1953). The polymer 
ization of tWo diphosphorylated isoprene building blocks 
(e.g., IPP and dimethylallyl) generates geranyl diphosphate 
(GPP), a linear C10 intermediate that can be converted to 
cyclic or linear end-products representing the monoterpenes, 
or used in another round of polymerization. The addition of 
a third isoprene unit to GPP generates farnesyl diphosphate 
(FPP), Which can also be converted to cyclic or linear 
products representing the sesquiterpene class. Continuing 
the polymerization and chemical differentiation cycle leads 
to the production of other classes of terpenoids named 
according to the number of isoprene building blocks leading 
to their biosynthesis, for example, the addition of a third IPP 
to FPP generates geranylgeranyl diphosphate (GGPP). 
These polymerization reactions are catalyzed by prenyl 
transferases that direct the attack of a carbocation (an 
electron de?cient carbon atom resulting from the loss of the 
diphosphate moiety of one substrate) to an electron-rich 
carbon atom of the double bond on the IPP molecule (FIG. 
2). The electrophilic nature of these reactions is said to be 
unusual relative to more general nucleophilic condensation 
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2 
reactions, but this appears to be a common reaction among 
isoprenoid biosynthetic enzymes and especially those 
enzymes involved in catalyzing the cyclization of various 
isoprenoid intermediates (Gershenzon and Croteau, In: Lipid 
Metabolism in Plants, Moore, T. S., ed., CRC Press, Boca 
Raton, Fla., pp. 3404388). The enzymes responsible for the 
cyclization of GPP, FPP, and GGPP are referred to as 
monoterpene, sesquiterpene, and diterpene synthases or 
synthases, and represent reactions committing carbon from 
the general isoprenoid pathWay to end products in the 
monoterpene, sesquiterpene, and diterpene classes, respec 
tively. 
TWo important biochemical distinctions betWeen the pre 
nyltransferase and synthase reactions are illustrated in FIG. 
2. The prenyltransferases catalyze carbon-carbon bond for 
mation betWeen tWo substrate molecules, Whereas the syn 
thases catalyze an intramolecular carbon-carbon bond for 
mation. The prenyltransferases also catalyze reactions With 
very little variance in the stereochemistry or length of the 
ensuing polymer. Prenyltransferases differ in the length of 
the allyic substrates that can be accepted in initiating these 
reactions. The synthases are also substrate speci?c. 
HoWever, diverse sesquiterpene synthases, for example, can 
utilize the same substrate to produce different reaction 
products. 
The biosynthesis of isoprenoids such as cyclic terpenes is 
said to be determined by key branch point enzymes referred 
to as terpene synthases. The reactions catalyzed by terpene 
synthases are complex, intramolecular cyclizations that may 
involve several partial reactions. For example, the bioor 
ganic rationale for the cyclization of FPP by tWo sesquiter 
pene synthases are shoWn in FIG. 3. In step 1, the initial 
ionization of FPP is folloWed by an intramolecular electro 
phillic attack betWeen the carbon bearing the diphosphate 
moiety and the distal double bond to form germacene A, a 
macrocylic intermediate. Internal ring closure and formation 
of the eudesmane carbonium ion constitutes step 2. For 
tobacco 5-epi-aristolochene synthase (TEAS), the terminal 
step is a hydride shift, methyl migration, and deprotonation 
at C9 giving rise to 5-epi-aristolochene as depicted in step 
3a. Hyoseyamus muticus vetispiradiene synthase (HVS) 
shares a common mechanism at steps 1 and 2, but differs 
from TEAS in the third partial reaction in Which a ring 
contraction Would occur due to alternative migration of an 
electron pair. In each case, a monomeric protein of approxi 
mately 64 kD catalyzes the complete set of partial reactions 
and requires no cofactors other than Mg+2. 
SUMMARY OF THE INVENTION 
In general, the invention features a chimeric isoprenoid 
synthase polypeptide including a ?rst domain from a ?rst 
isoprenoid synthase joined to a second domain from a 
second, heterologous isoprenoid synthase, Whereby the chi 
meric isoprenoid synthase is capable of catalyzing the 
production of isoprenoid reaction products that are not 
produced in the absence of the second domain of the second, 
heterologous isoprenoid synthase. In preferred 
embodiments, the chimeric isoprenoid synthase is capable of 
catalyzing at least tWo different isoprenoid reaction prod 
ucts; the isoprenoid reaction products are cyclic; the second 
domain of the second, heterologous isoprenoid synthase also 
determines the ratio of the isoprenoid reaction products of 
the chimeric isoprenoid synthase; the ?rst domain from the 
?rst isoprenoid synthase is a plant isoprenoid synthase and 
the second domain from the second, heterologous isoprenoid 
synthase is also from a plant isoprenoid synthase. 
Preferably, the chimeric isoprenoid synthase is chosen 
from the group consisting of (a) the tobacco-Hyoscyamus 
US 7,186,891 B1 
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CH4 chimeric isoprenoid synthase; (b) the tobacco 
Hyoscyamus CH10 chimeric isoprenoid synthase; (c) the 
tobacco-Hyoscyamus CH11 chimeric isoprenoid synthase; 
(d) the tobacco-Hyoscyamus CH12 chimeric isoprenoid 
synthase; (e) the tobacco-Hyoscyamus CH13 chimeric iso 
prenoid synthase; or (f) the tobacco-Hyoscyamus CH14 
chimeric isoprenoid synthase, all as described herein. 
In preferred embodiments, the chimeric isoprenoid syn 
thase catalyzes the production of an isoprenoid reaction 
product that is of agricultural, pharmaceutical, commercial, 
or industrial signi?cance (e.g., an antifungal agent, antibac 
terial agent, or antitumor agent). 
In other related aspects, the invention features DNA, 
vectors, and cells (for example, E. coli, Saccharomyces 
cerevisiae, animal or plant cells) encoding or containing a 
chimeric isoprenoid synthase polypeptide. 
In another aspect, the invention features a chimeric iso 
prenoid synthase polypeptide including an asymmetrically 
positioned homologous domain Whereby the chimeric iso 
prenoid synthase is capable of catalyZing the production of 
isoprenoid reaction products (preferably, cyclic products) 
When the domain is positioned at its naturally-occurring site 
in the isoprenoid synthase polypeptide. 
In another aspect, the invention features a method for 
producing a chimeric isoprenoid synthase polypeptide, the 
method involving: (a) providing a cell transformed With 
DNA encoding a chimeric isoprenoid synthase positioned 
for expression in the cell; (b) culturing the transformed cell 
under conditions for expressing the DNA; and (c) recovering 
the chimeric isoprenoid synthase. 
By “isoprenoid synthase” is meant a polypeptide that is 
capable of catalyZing a reaction involving the intramolecular 
carbon-carbon bond formation of an allylic diphosphate 
substrate (for example, a C10, C15, or C2O allylic diphosphate 
substrate) to an isoprenoid product (for example, a 
monoterpene, diterpene, sesquiterpene, or sterol product). 
Examples of such isoprenoid synthases include, Without 
limitation, monoterpene synthases (for example, limonene 
synthase), diterpene synthases (for example, casbene 
synthase), and sesquiterpene synthases (for example, 5-epi 
aristolochene synthase, vetispiradiene synthase, and 
cadinene synthase) that are responsible for cycliZation of 
geranyl diphosphate (GPP), farnesyl diphosphate (FPP), and 
geranylgeranyl diphosphate (GGPP), respectively. Anumber 
of terpene synthases from plant and microbial sources have 
been isolated and characterized (see, for example, Moestra 
and West, Arch. Biochem. Biophys. 2381325, 1985; Hohn 
and Van MiddlesWorth, Arch. Biochem. Biophys. 2511756, 
1986; Hohn and Plattner, Arch. Biochem. Biophys. 2721137, 
1989; Cane and Pargellis, Arch. Biochem. Biophys. 2541421, 
1987; Munck and Croteau, Arch. Biochem. Biophys. 282158, 
1990; Alonso et al., J. Biol. Chem. 26717582, 1992; Savage 
et al., J. Biol. Chem. 26914012, 1994; Croteau et al., Arch. 
Biochem. Biophys. 3091184, 1994; Vogeli et al., Plant 
Physiol. 931182, 1990; Guo et al., Arch. Biochem. Biophys. 
3081103, 1994; and Gambliel and Croteau, J. Biol. Chem. 
2591740, 1984). In general, terpene synthases are soluble 
enZymes having a molecular Weight of about 40 to 100 kD. 
Genes encoding a number of monoterpene, diterpene, and 
sesquiterpene synthases have been described for a number of 
plant and microbial organisms (see, for example, Hohn and 
Beremand, Gene 791131, 1989; Proctor and Hohn, J. Biol. 
Chem. 26814543, 1993; Facchini and Chappell, Proc. Natl. 
Acad. Sci. 89111088, 1992; Back and Chappell, J. Biol. 
Chem. 27017375, 1995; Colby et al., J. Biol. Chem. 
268123016, 1993; Mau and West, Proc. Natl. Acad. Sci. 
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9118497, 1994; Chen et al., Arch. Biochem. Biophys. 
3241255, 1994; and Cane et al., Biochemistry 3315846, 
1 994). 
By “polypeptide” or “protein” is meant any chain of 
amino acids, regardless of length or post-translational modi 
?cation (for example, glycosylation or phosphorylation). 
By “joined to” is meant covalently bonded either directly 
or indirectly (i.e., the domains are separated by an interven 
ing amino acid sequence). Such domains may be bonded by 
any means, including, Without limitation, a peptide bond or 
chemical linkage. 
By “domain” is meant a contiguous stretch of amino acids 
Within a polypeptide or protein. 
By “isoprenoid” is meant a compound that is derived from 
an isoprene building block. In particular, isoprenoid com 
pounds include, Without limitation, monoterpenes, 
diterpenes, sesquiterpenes, and sterols. As described herein, 
isoprenoids are found in a variety of organisms, for example, 
animal, fungal, or bacterial sources. 
By “asymmetrically positioned” is meant located Within 
the chimeric polypeptide at a site Which differs from its 
position in the naturally-occurring polypeptide. 
By “heterologous” is meant derived from different 
sources (in this case, different polypeptides). 
By “homologous” is meant derived from the same source 
(in this case, the same polypeptide). 
Other features and advantages of the invention Will be 
apparent from the folloWing description of the preferred 
embodiments thereof, and from the claims. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The draWings Will ?rst be described. 
FIG. 1 is a schematic illustration shoWing the isoprenoid 
biosynthetic pathWay With respect to the type of end prod 
ucts and their respective physiological functions. Broken 
arroWs indicate multiple steps or reactions. 
FIG. 2 is a schematic illustration shoWing the various 
reactions that are catalyZed by prenyltransferases and ter 
pene synthases. 
FIG. 3 is a schematic illustration shoWing a reaction 
mechanism for the synthesis of eremophilane (tobacco 
5-epi-aristolochene synthase, TEAS) and vetispiradiene 
(Hyoscyamus vetispiradiene synthase, HVS) type sesquit 
erpene synthases. Partial reactions 1 and 2 are considered 
common to both types of synthases. Mechanistic differences 
in partial reactions 3a and 3b are suf?cient to account for the 
different reaction products shoWn. 
FIG. 4A is a schematic illustration shoWing the chimeric 
constructs used to map catalytic domains Within sesquiter 
pene synthases. Line draWings depict composite diagrams 
for Wildtype (i.e., TEAS and HVS) and chimeric (CH1 
CH14) sesquiterpene synthase genes that Were engineered 
into the bacterial expression vector pGBT-T 19. Gene con 
structs Were prepared using a combination of the available 
restriction endonuclease sites and ampli?cation of select 
regions using PCR and PCR primers harboring convenient 
restriction endonuclease sites. Correspondence betWeen 
unique restriction endonuclease sites and amino acid posi 
tions are noted. 
FIG. 4B is a photograph of a TLC experiment shoWing 
synthase enZyme activities in sonicated lysates of E. coli 
TB1 cells expressing the TEAS, HVS, and chimeric syn 
thase constructs (CH1£H14) and measured using 3H-FPP. 
Reaction products Were separated by argentation-TLC and 
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detected by autoradiography. The radioactivity in 0.5 mm 
segments of each lane of an argentation-TLC plate Was 
determined in a scintillation counter, and radioactivity asso 
ciated With the Zones for the TEAS and HVS speci?c 
products Was set to 100%. 
FIG. 5 is a schematic illustration showing the correspon 
dence betWeen exons and functional domains Within iso 
prenoid synthases. The upper diagram represents the orga 
niZation of exons Within the TEAS gene, Which is nearly 
identical to that of the HVS and casbene synthase genes. The 
loWer diagram shoWs the alignment of functional domains to 
the exonic organiZation of the TEAS and HVS genes. Exon 
numbers are shoWn Within the upper diagram, and all other 
numbers refer to amino acid positions, some of Which 
correspond to the noted restriction endonuclease sites. 
FIG. 6 is a schematic diagram shoWing a domain sWitch 
ing strategy used to generate a quiescent synthase (QH1). 
Substituting the inactive HVS domain corresponding to 
exon 4 into CH3 results in a synthase having an altered 
enZyme activity. 
FIG. 7 is a schematic diagram of a domain sWitching 
strategy used for producing a chimeric quiescent-casbene 
synthase, and possible reaction products. 
FIG. 8 is a schematic illustration of a domain sWitching 
strategy for producing a chimeric quiescent-cadinene 
synthase, and possible reaction products. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Chimeric Isoprenoid Synthases 
Plasmids designed for expressing a chimeric synthase 
Were generated by substituting a portion of a gene encoding 
a domain from tobacco 5-epi-aristolochene synthase With a 
portion of a gene encoding a domain from Hyoscyamus 
vetispiradiene synthase. These plasmids Were expressed in 
bacteria, and bacterial lysates Were prepared and assayed for 
sesquiterpene synthase activity. The sesquiterpene synthase 
assays included an argentation-thin layer chromatography 
(TLC) analysis Which distinguished the aristocholene and 
vetispiradiene reaction products (Back and Chappell, J. Biol. 
Chem. 270:7375, 1995). As shoWn in FIG. 4A, fourteen 
chimeric synthase constructs Were generated and Were 
assayed as folloWs. 
Full-length cDNAs for the tobacco 5-epi-aristolochene 
synthase (TEAS) and Hyoscyamus vetispiradiene synthase 
(HVS) Were cloned into the EcoRI/Xhol sites of pBluescript 
SK (Stratagene), creating the pBSK-TEAS and pBSK-HVS 
plasmids, respectively (Back and Chappell, J. Biol. Chem. 
270:7375, 1995). The TEAS and HVS cDNA inserts ofthese 
expression plasmids Were oriented With their translation start 
codons neighboring the EcoRI restriction site and their 3' 
poly A tail ?anked by the Xhol restriction site of the pSK 
plasmid. 
Chimeric synthases CH1, CH2, CH5, and CH7 Were 
constructed by utiliZing the conserved HindIII and NdeI 
restriction sites found betWeen the tobacco and Hyoscyamus 
genes. CH1 Was prepared by ligating the 5' terminal portion 
of the TEAS gene (corresponding to the EcoRI to HindII 
fragment) With the 3' terminal portion of HVS gene 
(corresponding to the HindIII to KpnI fragment) into the 
bacterial expression vector pGBT-T19 (Gold 
Biotechnology) predigested With EcoRI and KpnI. 
CH2 Was prepared by ligating the 5' terminal portion of 
the TEAS gene (corresponding to the EcoRI to NdeI 
fragment) With the 3' terminal portion of HVS gene 
(corresponding to the NdeI to KpnI fragment) into pGBT 
T19. 
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CH5 Was prepared by ligating the 5' terminal portion of 
the HVS gene (corresponding to the EcoRI to HindIII 
fragment) With the 3' terminal portion of TEAS gene 
(corresponding to the HindIII to KpnI fragment) into pGBT 
T19. 
CH7 Was prepared by ligating the 5' terminal portion of 
the HVS gene (corresponding to the EcoRI to NdeI 
fragment) With the 3' terminal portion of TEAS gene 
(corresponding to the NdeI to KpnI fragment) into pGBT 
T19. 
CH3, CH4, CH12, and CH13 Were constructed using 
conventional polymerase chain reaction (PCR) 
methodologies, With primers designed for the ampli?cation 
of particular segments of the HVS gene. To facilitate direc 
tional cloning and maintenance of reading frame, primers 
Were also designed to contain convenient restriction sites. 
CH3 Was constructed as folloWs. An EcoRI/ClaI restric 
tion fragment of the TEAS gene Was isolated and ligated to 
the ClaI/KpnI fragment of the HVS gene. The HVS ClaI/ 
KpnI fragment Was prepared by PCR methodology using 
5'-d(GGGATCGATGACATAGCCACGTATGAGGTT)-3' 
(SEQ ID NO: 1; ClaI restriction site underlined) as the 
forWard primer and 5'-d(AATACGACTCACTATAG)-3' 
(SEQ ID NO: 2) as the reverse primer (corresponding to the 
T7 sequence found in the multiple cloning site of pBSK) 
using pBSK-HVS as the DNA template. The resulting 
restriction fragment Was ligated into the EcoRI/KpnI sites of 
the pGBT-T19 vector. 
CH4 and CH13 Were constructed in a similar manner, but 
using the forWard ampli?cation primers 5'-d(CGA 
GTCAACATGGTTTATTGAGGGATA)-3' (SEQ ID NO: 3; 
HincII restriction site underlined) and 5'-d(TAT 
TCTAGATCTCTATGACGATTATGAA)-3' (SEQ ID NO: 
4; XbaI restriction site underlined), respectively. 
CH12 Was prepared by ligating a PCR fragment corre 
sponding to the ?rst 1326 nucleotides of CH4 With the 
ClaI/KpnI fragment of the TEAS gene into the EcoRI/KpnI 
sites of the pGBT-T19 vector. The CH4 fragment Was 
prepared using forWard ampli?cation primer 5'-d 
( G G G A G C T C 
GAATTCCATGGCCTCAGCAGCAGTTGCAAACTAT)-3' 
(SEQ ID NO: 5; EcoRI restriction site underlined and 
translation start codon in bold) and reverse primer 5'-d(GGG 
ATCGATAACTCTGCATAATGTAGCATT)-3' (SEQ ID 
NO: 6; ClaI restriction site underlined). 
Chimeric synthases CH6, CH8, CH9, CH10, CH11, and 
CH14 Were constructed as folloWs. Ligation of the EcoRI/ 
HindIII fragment of the HVS gene With the HindIII/KpnI 
fragment of CH3 generated CH6. CH8 Was created by 
ligating the EcoRI/NdeI fragment of HVS With the NdeI/ 
KpnI fragment of CH3. CH9 Was created by ligating the 
EcoRI/NdeI fragment of CH5 With the NdeI/KpnI fragment 
of HVS. CH10 Was constructed by ligating the EcoRI/ 
HindIII fragment of HVS With the HindIII/KpnI fragment of 
CH4. CH11 Was constructed by ligating the EcoRI/NdeI 
fragment of HVS With the NdeI/KpnI fragment of CH4. And 
CH14 Was generated by substituting the EcoRI/NdeI frag 
ment of CH13 With the corresponding DNA fragment of pB 
SK-HVS. The nucleotide junctions of the chimeric con 
structs Were con?rmed by double-stranded DNA sequencing 
using the dideoxy nucleotide chain termination kit, accord 
ing to the manufacturer’s instructions (U.S. Biochemical 
Corp). 
Chimeric synthases Were expressed in E. coli TB1 cells. 
Procedures for groWth of the bacterial cells, induction of 
gene expression, measurement of sesquiterpene synthase 
enZyme activity, and the determination of total protein in the 
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bacterial lysates Were performed according to the methods 
described by Back and Chappell (Arch. Biochem. Biophys. 
315:527, 1994; J. Biol. Chem. 270:7375, 1995). Reaction 
products Were separated by developing G60 silica TLC 
plates impregnated With 15% silver nitrate in benzenezhex 
ane:diethyl ether (50: 50: 1). For qualitative evaluations, TLC 
plates Were sprayed With Enhance surface ?uorography 
spray (Dupont) and exposed to Kodak XAR-5 ?lm for 2 to 
5 days at —700 C. For quantitative evaluations, 0.5 mm zones 
of an entire lane from a TLC plates Were scraped into 
scintillation vials, and the radioactivity Was determined 
using a Packard 1500 Liquid Scintillation Counter. The 
dominant reaction products generated by the synthase activi 
ties resulting from expression of the TEAS, HVS, CH4, and 
CH14 constructs in bacterial lysates Were also veri?ed by 
gas chromatography (GC) and gas chromatography-mass 
spectroscopy (GC-MS) according to the conditions 
described by Chappell et al. (Phylochemislry 26:2259, 1987) 
(data not shoWn). In addition, mass spectra pro?les Were 
compared to that published for 5-epi-aristolochene (Anke 
and Sterner, Planla Med. 57:344, 1991) and the predicted 
fragmentation pattern for vetispiradiene (Enzell et al., Mass 
Spectrometry Rev. 3:395, 1984). 
As shoWn in FIGS. 4AiB, the dominant reaction product 
resulting from the expression of the tobacco TEAS gene 
expressed Was 5-epi-aristolochene, and vetispiradiene Was 
found to be the dominant reaction product resulting from the 
expression of the HVS gene. The predominant reaction 
products generated by the expression of CH1 and CH2 Were 
also HVS-speci?c (i.e., vetispiradiene), With enzyme spe 
ci?c activities similar to those found for HVS that Was 
expressed from the pBSK-HVS plasmid. These results indi 
cated that the amino-terminal half of TEAS and HVS Were 
functionally equivalent With respect to the HVS carboxy 
terminus and do not contribute to the speci?city of the 
reaction product. CH7, having an HVS amino terminus and 
a TEAS carboxy terminus, is the converse construct of CH2, 
and the resulting synthase activity Was expected to result in 
expression of a TEAS-speci?c product (i.e., 5-epi 
aristolochene). Immunodetection assays revealed that syn 
thase protein produced upon expression of CH7 Was found 
to be of the correct size and expected abundance (data not 
shoWn); hoWever, no enzyme activity Was detected. The lack 
of enzyme activity indicated that interactions betWeen the 
carboxy and amino terminal portions of the protein contrib 
uted to enzyme activity. This interpretation is further sup 
ported by comparing the speci?c activity of the enzymes 
generated by the expression of the CH5 and CH6 constructs. 
CH5 resulted in the expression of a product having a 10-fold 
loWer speci?c activity of synthase enzyme activity than the 
other chimeric synthases, even though the absolute level of 
expressed protein Was similar to the other constructs (as 
determined by immunodetection, data not shoWn). Substi 
tuting an HVS carboxy-terminal region Was found to restore 
the speci?c activity to the synthase enzyme that Was gen 
erated by CH6. 
Comparison of CH2 and CH3 chimeric synthases pro 
vided evidence for speci?city of end-product formation 
residing Within a domain of approximately 181 amino acids, 
corresponding to the NdeI and ClaI restriction sites Within 
the TEAS and HVS genes. Expression of CH4 unexpectedly 
resulted in the production of a chimeric synthase protein 
capable of generating reaction products re?ective of both the 
TEAS and HVS enzymes. We interpreted this result to 
indicate that amino acids 261 to 379 Within the tobacco 
5-epi-aristolochene synthase are responsible for the TEAS 
speci?c products (i.e., the region corresponding to the NdeI 
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to HincII fragment of the cDNA), While amino acids 379 to 
442 Within the Hyoscyamus protein are responsible for the 
HVS-speci?c products (i.e., the region corresponding to the 
HincII to ClaI fragment of the cDNA). 
Our interpretation Was con?rmed by evaluating the 
expression products of CH11 and CH12. CH11 represented 
the substitution of the NdeI to HincII fragment of the 
Hyoscyamus gene With the corresponding tobacco gene 
fragment, and resulted in the production of an enzyme 
having HVS- and TEAS-speci?city. CH12 represented a 
substitution of the HincII to ClaI fragment of the tobacco 
gene With the corresponding Hyoscyamus gene fragment, 
and resulted in the production of an enzyme having HVS 
and TEAS-speci?city. Comparing CH11 to CH13 provided 
a further re?nement in the domain characterization of the 
tobacco enzyme responsible for the TEAS-speci?c products. 
The fact that CH13 Was found to be a multifunctional 
enzyme indicated that the 81 amino acids encoded by the 
DNA fragment residing betWeen the NdeI to XbaI restriction 
sites of the tobacco cDNA Were su?icient for formation of 
the predominant TEAS speci?c products. This interpretation 
Was con?rmed by substituting the domain contained Within 
the NdeI/XbaI HVS cDNA restriction fragment of CH14 
With that of the TEAS gene (FIG. 4A). 
As shoWn in FIG. 4B, the predominant reaction product(s) 
of the Wildtype tobacco TEAS and Hyoscyamus HVS genes 
expressed in bacteria migrated on silver nitrate-TLC plates 
With Rf values of 0.41 and 0.31, values consistent With 
previous characterization of these products as 5-epi 
aristolochene and vetispiradiene, respectively (Back and 
Chappell, J. Biol. Chem. 270:7375, 1995; Back et al., Arch. 
Biochem. Biophys. 3152527, 1994). GC and GC-MS analy 
ses indicated that the predominant TEAS reaction products 
Were 5-epi-aristolochene (70% of total products, based on 
percentage of total peak areas from GC analysis) and a 
bicyclic sesquiterpene (20%) ([M]+ ion at m/z of 204). The 
predominant HVS reaction product Was vetispiradiene 
(>90%) ([M]+ ion at m/z of 204 With a base peak at m/z 41 
and a series ofpredictable ions at m/z 175, 108, 94, and 68), 
and the predominant reaction products of CH4 Were 5-epi 
aristolochene (18%), a bicyclic sesquiterpene (43%), and 
vetispiradiene (32%) (data not shoWn). 
In addition, studies relying on a?inity puri?cation of 
histidine-tagged recombinant synthase proteins has revealed 
?ve other minor reaction products, each representing 
approximately 1% of the total products, With all ?ve found 
at the same relative abundance in all the reaction assays. 
Ratio-Determinant Domain 
Another domain of the synthase proteins Was identi?ed by 
comparing the relative ratio of the predominant reaction 
products produced by the multifunctional chimeric synthase 
enzymes (FIG. 4A). For example, the reaction products 
resulting from expression of constructs CH4, CH10, CH11, 
and CH12 Were generated in a ratio of 60*70% TEAS 
speci?c to 30*40% HVS-speci?c. In contrast, an inverse 
ratio of reaction products resulted from expression of con 
structs CH13 and CH14. This result indicated that the region 
encompassed by the XbaI to HincII domain in?uenced the 
relative ratio of reaction products generated by the multi 
functional chimeric synthase enzymes. These results indi 
cated that tWo separate and distinct domains Within the 
synthase peptide contributed directly to the types of reaction 
products generated, and are interrupted by another domain 
Which We refer to as the ratio-determinant domain (FIG. 5). 
Site-Directed Mutagenesis 
Additional analysis of the product speci?city and ratio 
determinant domains Was determined using conventional 
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site-directed mutagenesis methodologies. The results of this 
analysis are presented in Table I (below). For example, the 
DDXXD motif, found Within the aristolochene speci?c 
domain, is a conserved sequence that is found in a variety of 
terpene biosynthetic enzymes including TEAS and HVS. 
This acidic amino acid cluster is said to coordinate a metal 
cofactor that is necessary to neutralize the diphosphate 
moiety of FPP in an otherWise lipophilic pocket. Substitu 
tion of the ?rst aspartic acid residue (D301) of the DDXXD 
motif With either glutamic acid (overall charge conservation) 
or valine (net loss of acidic charge) residues (i.e., D301—>E 
and D301QV) resulted in the formation of an inactivated 
enzyme. A conserved substitution of the second aspartic acid 
(D302) With a glutamic acid residue (i.e., D302—>E) also 
inactivated chimeric synthase enzyme activity by 95%, and 
resulted in a slight alteration of the product distribution of 
the multifunctional enzyme. 
TABLE I 
Product ratio Speci?c 
Mutation Mutated Aristo- Vetis- Activity 
target gene amino acid lochene piradiene (nmol/mg hi1) 
CH4 66% 34% 34 
Substrate binding domain (Ndel/Xbal region) 
Tobacco D301V No 0 
activity 
CH4 R287A No 0 
activity 
CH4 D301V No 0 
activity 
CH4 D301E No 0 
activity 
CH4 D302E 51% 49% 1.8 
Ratio determinant domain (Xbal/HincII region) 
CH4 K347I 64% 36% 32 
CH4 H360S 63% 32% 29 
CH4 H364S 65% 35% 38 
Hyoscyalnus speci?c domain (HincII/ClaI region) 
CH4 T408A 67% 33% 48 
CH4 K420M 68% 32% 29 
CH4 H422A 67% 33% 30 
CH4 N436S 70% 30% 32 
CH4 AT437, 61% 39% 33 
43 8VI 
The sites for directed substitutions Within the ratio 
determinant domain (i.e., K347QI, H360QS, H364QS) 
Were inferred by an analysis of reports that hypothesized the 
importance of charged amino acid residues (e.g., histidine or 
lysine) in synthase enzymology, and these sites represented 
those amino acids Which displayed the greatest charge 
differences in comparisons betWeen the TEAS and HVS 
primary sequences. None of the three mutations analyzed 
had any effect on overall catalytic activity or the ratio of 
products formed. 
Amino acid substitutions Within the HVS speci?c domain 
Were chosen on the basis of comparisons betWeen secondary 
structural predictions of the HVS and TEAS proteins. Those 
amino acids mutated appeared to contribute disproportion 
ately to structural distortions in the secondary structure 
models of these tWo proteins, largely because of charge 
considerations. HoWever, as shoWn in Table I (above), 
substitutions involving charged to non-charged (i.e., 
T408—>A, K420—>M, H422—>A) or reduced charged 
(N436—>S, A437—>T, V438—>I) amino acids did not affect 
overall enzyme activity, nor the synthesis rate of one product 
or the other. 
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Quiescent Synthases 
To generate a quiescent synthase, the inactive domain 
corresponding to exon 4 of HVS is substituted With the 
corresponding active domain of CH3, as outlined in FIG. 6. 
CH3 contains an inactive domain corresponding to exon 6 of 
TEAS, has convenient NdeI and XbaI restriction sites for the 
desired substitution, and can be overexpressed in bacteria to 
high levels. Domain sWitching is accomplished using stan 
dard molecular techniques, as described herein. In one 
particular example, a PCR ampli?cation product of HVS 
cDNA corresponding to exon 4, encompassing amino acids 
261 to 342 and containing appropriate NdeI and XbaI sites 
Within the primers, is substituted for the corresponding 
region of CH3. In generating such constructs, care is exer 
cised to maintain appropriate amino acid residues and the 
correct reading frame, and expression testing of the con 
struct entails a measurement of the protein level in the 
soluble and insoluble fractions of bacterial lysates by immu 
noblotting techniques, as Well as by enzyme assays. 
In addition, large scale enzyme reactions are performed, 
the reaction product(s) are extracted into hexane, and the 
products are puri?ed by HPLC methods. Additional evalu 
ation of the quiescent enzyme reaction products is carried 
out using TLC, and comparing the Rf values of the experi 
mental sample to those generated by the TEAS and HVS 
enzymes. Retention times of the reaction products (e.g., 
germacrene or germacrene-like reaction product) are also 
monitored using GC, GC-MS, and NMR according to stan 
dard methods. 
The quiescent synthase is useful for providing sufficient 
amounts of the germacrene reaction intermediate(s) (or 
derivatives thereof) to con?rming the chemical rationaliza 
tion for the EAS and VS reactions, and produces a template 
chimeric synthase that may be used for the introduction of 
novel terminal steps in the overall synthase reaction scheme. 
Chimeric Casbene and Cadinene Synthases 
Chimeric isoprenoid synthases are also useful for gener 
ating novel macrocyclic isoprenoids or isoprenoids having 
altered stereochemical properties. For example, isoprenoid 
synthases such as casbene synthase, a diterpene synthase 
Which catalyzes the synthesis of a macrocyclic diterpene 
harboring a cyclopropyl side group, and cadiene synthase, a 
sesquiterpene synthase that catalyzes the synthesis of a 
bicyclic sesquiterpene, provide domains useful for engineer 
ing enzymes capable of producing macrocylic isoprenoids or 
isoprenoid reaction products having altered sterochemical 
properties. A general scheme for producing such chimeric 
synthases is presented in FIGS. 7 and 8. 
To construct such chimeric casbene and cadienne 
synthases, quiescent amino terminal domains (and other 
synthase domains as necessary) are substituted With those 
from casbene and cadinene synthase using convenient 
restriction sites and PCR ampli?cation of selected regions as 
described above. Sequences corresponding to the 
N-terminal, plastid targeting sequence of the casbene syn 
thase are deleted in these constructs. Chimeric constructs are 
expressed in bacteria, bacterial lysates are examined for 
chimeric synthase activity, and reaction products are char 
acterized as described above, for example, using 
argentation-TLC. Constructs supporting high levels of syn 
thase activity in bacteria and/or activity generating reaction 
products Which migrate With Rfs different from aris 
tolochene and vetispiradiene standards are considered useful 
in the invention. Reaction products are also analyzed for 
their retention times by GC and subjected to GC-MS and 
NMR, as necessary. Those domains of casbene synthase and 
cadinene synthase Which contribute to the synthesis of 
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unique reaction products may also be subjected to ?ne detail 
mapping using a strategy analogous to that depicted in FIG. 
4A. 
Production of Other Chimeric Isoprenoid Synthases 
Using the standard molecular techniques described 
herein, other chimeric synthases may be readily generated 
Which include domains from knoWn or neWly isolated 
synthase enZymes. Such chimeric synthases may be tested 
for activity using, for example, any appropriate enZyme 
assays knoWn to those in the art, or by standard immuno 
detection techniques. 
The isolation of additional synthase coding sequences is 
also possible using standard cloning strategies and tech 
niques that are Well knoWn in the art. For example, using all 
or a portion of the amino acid sequence of a knoWn synthase 
polypeptide, one may readily design synthase-speci?c oli 
gonucleotide probes, including synthase degenerate oligo 
nucleotide probes (i.e., a mixture of all possible coding 
sequences for a given amino acid sequence). These oligo 
nucleotides may be based upon the sequence of either DNA 
strand and any appropriate portion of synthase nucleotide 
sequence. General methods for designing and preparing 
such probes are provided, for example, in Ausubel et al., 
1996, Current Protocols in Molecular Biology, Wiley 
Interscience, NeW York, and Berger and Kimmel, Guide to 
Molecular Cloning Techniques, 1987, Academic Press, NeW 
York. These oligonucleotides are useful for synthase gene 
isolation, either through their use as probes capable of 
hybridiZing to a synthase complementary sequences or as 
primers for various ampli?cation techniques, for example, 
polymerase chain reaction (PCR) cloning strategies. 
Hybridization techniques and screening procedures are 
Well knoWn to those skilled in the art and are described, for 
example, in Ausubel et al. (supra); Berger and Kimmel 
(supra); Chen at al. Arch. Biochem. Biophys. 324:255, 1995; 
and Sambrook et al., Molecular Cloning: A Laboratory 
Manual, Cold Spring Harbor Laboratory Press, NeW York. If 
desired, a combination of different oligonucleotide probes 
may be used for the screening of a recombinant DNA library. 
The oligonucleotides may be detectably-labeled using meth 
ods knoWn in the art and used to probe ?lter replicas from 
a recombinant DNA library. Recombinant DNA libraries are 
prepared according to methods Well knoWn in the art, for 
example, as described in Ausubel et al. (supra), or they may 
be obtained from commercial sources. 
As discussed above, synthase oligonucleotides may also 
be used as primers in ampli?cation cloning strategies, for 
example, using PCR. PCR methods are Well knoWn in the art 
and are described, for example, in PCR Technology, Erlich, 
ed., Stockton Press, London, 1989; PCR Protocols: A Guide 
to Methods and Applications, Innis et al., eds., Academic 
Press, Inc., NeW York, 1990; and Ausubel et al. (supra). 
Primers are optionally designed to alloW cloning of the 
ampli?ed product into a suitable vector, for example, by 
including appropriate restriction sites at the 5' and 3' ends of 
the ampli?ed fragment (as described herein). If desired, a 
synthase gene may be isolated using the PCR “RACE” 
technique, or Rapid Ampli?cation of cDNA Ends (see, e.g., 
Innis et al. (supra)). By this method, oligonucleotide primers 
based on a synthase sequence are oriented in the 3' and 5' 
directions and are used to generate overlapping PCR frag 
ments. These overlapping 3'- and 5'-end RACE products are 
combined to produce an intact full-length cDNA. This 
method is described in Innis et al. (supra); and Frohman et 
al., Proc. Natl. Acad. Sci. USA 8518998, (1988). 
Useful synthase sequences may be isolated from any 
appropriate organism. Con?rmation of a sequence’s relat 
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edness to the synthase polypeptide family may be accom 
plished by a variety of conventional methods, for example, 
sequence comparison. In addition, the activity of any syn 
thase protein may be evaluated according to any of the 
techniques described herein. 
Chimeric Isoprenoid Synthase Polypeptide Expression 
Chimeric synthase polypeptides may be produced by 
transformation of a suitable host cell With all or part of a 
chimeric synthase DNA (for example, the chimeric synthase 
cDNAs described above) in a suitable expression vehicle or 
With a plasmid construct engineered for increasing the 
expression of a chimeric synthase polypeptide in vivo. 
Those skilled in the ?eld of molecular biology Will 
appreciate that any of a Wide variety of expression systems 
may be used to provide the recombinant protein. The precise 
host cell used is not critical to the invention. The chimeric 
synthase protein may be produced in a prokaryotic host, for 
example, E. coli TB1, or in a eukaryotic host, for example, 
Saccharomyces cerevisiae, mammalian cells (for example, 
COS 1 or NIH 3T3 cells), or any of a number of plant cells 
including, Without limitation, algae, tree species, ornamental 
species, temperate fruit species, tropical fruit species, veg 
etable species, legume species, monocots, dicots, or in any 
plant of commercial or agricultural signi?cance. Particular 
examples of suitable plant hosts include, but are not limited 
to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis, 
Lettuce, Sun?ower, Oilseed rape, Flax, Cotton, Sugarbeet, 
Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna, 
Cucumber, Carrot, Eggplant, Cauli?ower, Horseradish, 
Morning Glory, Poplar, Walnut, Apple, Asparagus, Rice, 
Maize, Millet, Onion, Barley, Orchard grass, Oat, Rye, and 
Wheat. 
Such cells are available from a Wide range of sources 
including: the American Type Culture Collection (Rockland, 
Md.); or from any of a number seed companies, for example, 
W. Atlee Burpee Seed Co. (Warminster, Pa.), Park Seed Co. 
(Greenwood, SC), Johnny Seed Co. (Albion, Me.), or 
Northrup King Seeds (Harstville, S.C.). Descriptions and 
sources of useful host cells are also found in Vasil I. K., Cell 
Culture and Somatic Cell Genetics ofPlants, Vol I, II, III 
Laboratory Procedures and Their Applications Academic 
Press, NeW York, 1984; Dixon, R. A., Plant Cell Culture-A 
Practical Approach, IRL Press, Oxford University, 1985; 
Green et al., Plant Tissue and Cell Culture, Academic Press, 
NeW York, 1987; and Gasser and Fraley, Science 244: 1293, 
(1989). 
For prokaryotic expression, DNA encoding a chimeric 
synthase polypeptide is carried on a vector operably linked 
to control signals capable of e?fecting expression in the 
prokaryotic host. If desired, the coding sequence may 
contain, at its 5' end, a sequence encoding any of the knoWn 
signal sequences capable of e?fecting secretion of the 
expressed protein into the periplasmic space of the host cell, 
thereby facilitating recovery of the protein and subsequent 
puri?cation. Prokaryotes most frequently used are various 
strains of E. coli; hoWever, other microbial strains may also 
be used. Plasmid vectors are used Which contain replication 
origins, selectable markers, and control sequences derived 
from a species compatible With the microbial host. 
Examples of such vectors are found in PouWels et al. (supra) 
or Ausubel et al. (supra). Commonly used prokaryotic 
control sequences (also referred to as “regulatory elements”) 
are de?ned herein to include promoters for transcription 
initiation, optionally With an operator, along With ribosome 
binding site sequences. Promoters commonly used to direct 
protein expression include the beta-lactamase 
(penicillinase), the lactose (lac), the tryptophan (Trp) 
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(Goeddel et al., Nucl. Acids Res. 814057 (1980)), and the tac 
promoter systems, as Well as the lambda-derived PL pro 
moter and N-gene ribosome binding site (Simatake et al., 
Nature 292:128 (1981)). 
One particular bacterial expression system for chimeric 
synthase polypeptide production is the E. coli pET expres 
sion system (Novagen). According to this expression 
system, DNA encoding a chimeric synthase polypeptide is 
inserted into a pET vector in an orientation designed to alloW 
expression. Since the chimeric synthase gene is under the 
control of the T7 regulatory signals, expression of chimeric 
synthase is induced by inducing the expression of T7 RNA 
polymerase in the host cell. This is typically achieved using 
host strains Which express T7 RNA polymerase in response 
to lPTG induction. Once produced, recombinant chimeric 
synthase polypeptide is then isolated according to standard 
methods knoWn in the art, for example, those described 
herein. 
Another bacterial expression system for chimeric syn 
thase polypeptide production is the pGEX expression system 
(Pharmacia). This system employs a GST gene fusion sys 
tem that is designed for high-level expression of a gene or 
gene fragment as a fusion protein With rapid puri?cation and 
recovery of the functional gene product. The chimeric 
synthase protein of interest is fused to the carboxyl terminus 
of the glutathione S-transferase protein from Schistosoma 
japonicum and is readily puri?ed from bacterial lysates by 
af?nity chromatography using Glutathione Sepharose 4B. 
Fusion proteins can be recovered under mild conditions by 
elution With glutathione. Cleavage of the glutathione 
S-transferase domain from the fusion protein is facilitated by 
the presence of recognition sites for site-speci?c proteases 
upstream of this domain. For example, proteins expressed in 
pGEX-2T plasmids may be cleaved With thrombin; those 
expressed in pGEX-3X may be cleaved With factor Xa. 
For eukaryotic expression, the method of transformation 
or transfection and the choice of vehicle for expression of 
the chimeric synthase polypeptide Will depend on the host 
system selected. Transformation and transfection methods of 
numerous organisms, for example, the baker’s yeast Sac 
charomyces cerevisiae, are described, e.g., in Ausubel et al. 
(supra); Weissbach and Weissbach, Methods for Plant 
Molecular Biology, Academic Press, 1989; Gelvin et al., 
Plant Molecular Biology Manual, KluWer Academic 
Publishers, 1990; Kindle, K., Proc. Natl. Acad. Sci. USA 
8711228 (1990); Potrykus, 1., Annu. Rev. Plant Physiol. 
Plant Mol. Biology 42:205 (1991); and BioRad (Hercules, 
Calif.) Technical Bulletin #1687 (Biolistic Particle Delivery 
Systems). Expression vehicles may be chosen from those 
provided, e.g., in Cloning Vectors: A Laboratory Manual (P. 
H. PouWels et al., 1985, Supp. 1987); Gasser and Fraley 
(supra); Clontech Molecular Biology Catalog (Catalog 
1992/93 Tools for the Molecular Biologist, Palo Alto, 
Calif.); and the references cited above. 
One preferred eukaryotic expression system is the mouse 
3T3 ?broblast host cell transfected With a pMAMneo 
expression vector (Clontech). pMAMneo provides: an RSV 
LTR enhancer linked to a dexamethasone-inducible MMTV 
LTR promotor, an SV40 origin of replication Which alloWs 
replication in mammalian systems, a selectable neomycin 
gene, and SV40 splicing and polyadenylation sites. DNA 
encoding a chimeric synthase polypeptide is inserted into the 
pMAMneo vector in an orientation designed to alloW 
expression. The recombinant chimeric synthase polypeptide 
is then isolated as described beloW. Other preferable host 
cells Which may be used in conjunction With the pMAMneo 
expression vehicle include COS cells and CHO cells (ATCC 
Accession Nos. CRL 1650 and CCL 61, respectively). 
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Alternatively, if desired, a chimeric synthase polypeptide 
is produced by a stably-transfected mammalian cell line. A 
number of vectors suitable for stable transfection of mam 
malian cells are available to the public, e.g., see PouWels et 
al. (supra); methods for constructing such cell lines are also 
publicly available, e.g., in Ausubel et al. (supra). In one 
example, cDNA encoding the chimeric synthase polypeptide 
is cloned into an expression vector Which includes the 
dihydrofolate reductase (DHFR) gene. Integration of the 
plasmid and, therefore, the chimeric synthase-encoding gene 
into the host cell chromosome is selected for by inclusion of 
0.0li300 uM methotrexate in the cell culture medium (as 
described in Ausubel et al., supra). This dominant selection 
can be accomplished in most cell types. Recombinant pro 
tein expression can be increased by DHFR-mediated ampli 
?cation of the transfected gene. Methods for selecting cell 
lines bearing gene ampli?cations are described in Ausubel et 
al. (supra); such methods generally involve extended culture 
in medium containing gradually increasing levels of meth 
otrexate. DHFR-containing expression vectors commonly 
used for this purpose include pCVSEll-DHrF and 
pAdD26SV(A) (described in Ausubel et al., supra). Any of 
the host cells described above or, preferably, a DHFR 
de?cient CHO cell line (for example, CHO DHFR-cells, 
ATCC Accession No. CRL 9096) are among the host cells 
preferred for DHFR selection of a stably-transfected cell line 
or DHFR-mediated gene ampli?cation. 
A chimeric synthase polypeptide is preferably produced 
by a stably-transfected plant cell line or by a transgenic 
plant. A number of vectors suitable for stable transfection of 
plant cells or for the establishment of transgenic plants are 
available to the public; such vectors are described in Pou 
Wels et al. (supra), Weissbach and Weissbach (supra), and 
Gelvin et al. (supra). Methods for constructing such cell 
lines are described in, e.g., Weissbach and Weissbach 
(supra), and Gelvin et al. (supra). Typically, plant expression 
vectors include (1) a cloned chimeric synthase gene under 
the transcriptional control of 5' and 3' regulatory sequences 
and (2) a dominant selectable marker. Such plant expression 
vectors may also contain, if desired, a promoter regulatory 
region (for example, one conferring inducible or constitutive 
expression, or environmentally- or developmentally 
regulated, or pathogen- or Wound-inducible, or cell- or 
tissue-speci?c expression), a transcription initiation start 
site, a ribosome binding site, an RNA processing signal, a 
transcription termination site, and/or a polyadenylation sig 
nal. 
The chimeric synthase DNA sequence of the invention 
may, if desired, be combined With other DNA sequences in 
a variety of Ways. The chimeric synthase DNA sequence of 
the invention may be employed With all or part of the gene 
sequences normally associated With a synthase protein. In its 
component parts, a DNA sequence encoding a chimeric 
synthase protein is combined in a DNA construct having a 
transcription initiation control region capable of promoting 
transcription and translation in a host cell. 
In general, the constructs Will involve regulatory regions 
functional in plants Which provide for production of a 
chimeric synthase protein as discussed herein. The open 
reading frame coding for the chimeric synthase protein or 
functional fragment thereof Will be joined at its 5' end to a 
transcription initiation regulatory region such as the 
sequence naturally found in the 5' upstream region of a 
synthase structural gene. Numerous other transcription ini 
tiation regions are available Which provide for constitutive 
or inducible regulation. 
For applications When developmental, cell, tissue, 
hormonal, environmental, or pathogen-inducible expression 
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are desired, appropriate 5' upstream non-coding regions are 
obtained from other genes; for example, from genes regu 
lated during seed development, embryo development, leaf 
development, or in response to a pathogen. 
Regulatory transcript termination regions may also be 
provided in DNA constructs of this invention as Well. 
Transcript termination regions may be provided by the DNA 
sequence encoding a synthase protein or any convenient 
transcription termination region derived from a different 
gene source. The transcript termination region Will contain 
preferably at least 143 kb of sequence 3' to the structural 
gene from Which the termination region is derived. Such 
genetically-engineered plants are useful for a variety of 
industrial and agricultural applications as discussed beloW. 
lmportantly, this invention is applicable to gymnosperms 
and angiosperms, and Will be readily applicable to any neW 
or improved transformation or regeneration method. 
An example of a useful plant promoter according to the 
invention is a caulimovirus promoter, for example, a cauli 
?oWer mosaic virus (CaMV) promoter. These promoters 
confer high levels of expression in most plant tissues, and 
the activity of these promoters is not dependent on virally 
encoded proteins. CaMV is a source for both the 35S and 
19S promoters. In most tissues of transgenic plants, the 
CaMV 35S promoter is a strong promoter (see, e.g., Odell et 
al., Nature 313:810 (1985)). The CaMV promoter is also 
highly active in monocots (see, e.g., Dekeyser et al., Plant 
Cell 2:591 (1990); Terada and Shimamoto, Mol. Gen. Genet. 
220:389, (1990)). Moreover, activity of this promoter can be 
further increased (i.e., betWeen 2410 fold) by duplication of 
the CaMV 35S promoter (see e.g., Kay et al., Science 
236:1299 (1987); OW et al., Proc. Natl. Acad. Sci. USA. 
84:4870 (1987); and Fang et al., Plant Cell 1:141 (1989)). 
Other useful plant promoters include, Without limitation, 
the nopaline synthase promoter (An et al., Plant Physiol. 
88:547 (1988)) and the octopine synthase promoter (Fromm 
et al., Plant Cell 1:977 (1989)). 
For certain applications, it may be desirable to produce 
the chimeric synthase gene product in an appropriate tissue, 
at an appropriate level, or at an appropriate developmental 
time. For this purpose, there are an assortment of gene 
promoters, each With its oWn distinct characteristics embod 
ied in its regulatory sequences, shoWn to be regulated in 
response to the environment, hormones, and/or developmen 
tal cues. These include gene promoters that are responsible 
for heat-regulated gene expression (see, e.g., Callis et al., 
Plant Physiol. 88:965 (1988); Takahashi and Komeda, Mol. 
Gen. Genet. 219:365 (1989); and Takahashi et al. Plant J. 
2:751 (1992)), light-regulated gene expression (e.g., the pea 
rbcS-3A described by Kuhlemeier et al. (Plant Cell 1:471 
(1989); the maiZe rbcS promoter described by Schalfner and 
Sheen, (Plant Cell 3:997 (1991); or the chlorophyll a/b 
binding protein gene found in pea described by Simpson et 
al. (EMBO J. 4:2723 (1985)), hormone-regulated gene 
expression (for example, the abscisic acid (ABA) responsive 
sequences from the Em gene of Wheat described by Marcotte 
et al. (Plant Cell 1:969 (1989); the ABA-inducible HVAl 
and HVA22, and the rd29A promoters described for barley 
and Arabidopsis by Straub et al. (Plant Cell 6:617 (1994), 
Shen et al. (Plant Cell 7:295 (1994)), and Wound-induced 
gene expression (for example, of Wunl described by SiebertZ 
et al. (Plant Cell 1:961 (1989)), or organ-speci?c gene 
expression (for example, of the tuber-speci?c storage pro 
tein gene described by Roshal et al. (EMBO J. 6:1155 
(1987); the 23-kDa Zein gene from maiZe described by 
Schemthaner et al. (EMBO J. 7:1249 (1988); or the French 
bean [3-phaseolin gene described by Bustos et al. (Plant Cell 
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1:839 (1989)); and pathogen-inducible gene expression 
described by Chappell et al. in US. Ser. Nos. 08/471,983, 
08/443,639, and 08/ 577,483, hereby incorporated by refer 
ence. 
Plant expression vectors may also optionally include 
RNA processing signals, for example, introns, Which have 
been shoWn to be important for ef?cient RNA synthesis and 
accumulation (Callis et al., Genes and Dev. 1:1183 (1987)). 
The location of the RNA splice sequences can dramatically 
in?uence the level of transgene expression in plants. In vieW 
of this fact, an intron may be positioned upstream or 
doWnstream of a chimeric synthase polypeptide-encoding 
sequence in the transgene to modulate levels of gene expres 
sion. 
In addition to the aforementioned 5' regulatory control 
sequences, the expression vectors may also include regula 
tory control regions Which are generally present in the 3' 
regions of plant genes (Thomburg et al., Proc. Natl. Acad. 
Sci. USA. 84:744 (1987); An et al., Plant Cell 1:115 
(1989)). For example, the 3' terminator region may be 
included in the expression vector to increase stability of the 
mRNA. One such terminator region may be derived from the 
Pl-ll terminator region of potato. In addition, other com 
monly used terminators are derived from the octopine or 
nopaline synthase signals. 
The plant expression vector also typically contains a 
dominant selectable marker gene used to identify those cells 
that have become transformed. Useful selectable genes for 
plant systems include genes encoding antibiotic resistance 
genes, for example, those encoding resistance to 
hygromycin, kanamycin, bleomycin, G418, streptomycin, or 
spectinomycin. Genes required for photosynthesis may also 
be used as selectable markers in photosynthetic-de?cient 
strains. Alternatively, the green-?uorescent protein from the 
jelly?sh Aequorea victoria may be used as a selectable 
marker (Sheen et al., Plant J. 8:777, 1995; Chiu et al., 
Current Biology 6:325 (1996)). Finally, genes encoding 
herbicide resistance may be used as selectable markers; 
useful herbicide resistance genes include the bar gene 
encoding the enZyme phosphinothricin acetyltransferase and 
conferring resistance to the broad spectrum herbicide 
Basta® (Hoechst AG, Frankfurt, Germany). 
Ef?cient use of selectable markers is facilitated by a 
determination of the susceptibility of a plant cell to a 
particular selectable agent and a determination of the con 
centration of this agent Which effectively kills most, if not 
all, of the transformed cells. Some useful concentrations of 
antibiotics for tobacco transformation include, e.g., 754100 
ug/ml (kanamycin), 20450 ug/ml (hygromycin), or 5410 
ug/ml (bleomycin). A useful strategy for selection of trans 
formants for herbicide resistance is described, e.g., by Vasil 
et al., supra. 
It should be readily apparent to one skilled in the art of 
molecular biology, especially in the ?eld of plant molecular 
biology, that the level of gene expression is dependent, not 
only on the combination of promoters, RNA processing 
signals, and terminator elements, but also -on hoW these 
elements are used to increase the levels of selectable marker 
gene expression. 
Plant Transformation 
Upon construction of the plant expression vector, several 
standard methods are available for introduction of the vector 
into a plant host, thereby generating a transgenic plant. 
These methods include (1) Agrobacterium-mediated trans 
formation (A. tumefaciens or A. rhizogenes) (see, e.g., Lich 
tenstein and Fuller ln: Genetic Engineering, vol 6, P W J 
Rigby, ed, London, Academic Press, 1987; and Lichtenstein, 
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C. P., and Draper, 1,. In: DNA Cloning, Vol II, D. M. Glover, 
ed, Oxford, IRI Press, 1985)), (2) the particle delivery 
system (see, e.g., Gordon-Kamm et al., Plant Cell 2:603 
(1990); or BioRad Technical Bulletin 1687, supra), (3) 
microinjection protocols (see, e.g., Green et al., supra), (4) 
polyethylene glycol (PEG) procedures (see, e.g., Draper et 
al., Plant Cell Physiol. 23:451 (1982); or e.g., Zhang and 
Wu, Theor Appl. Genet. 76:835 (1988)), (5) liposome 
mediated DNA uptake (see, e.g., Freeman et al., Plant Cell 
Physiol. 25:1353 (1984)), (6) electroporation protocols (see, 
e.g., Gelvin et al., supra; Dekeyser et al., supra; Fromm et 
al., Nature 319:791 (1986); Sheen, Plant Cell 2:1027 
(1990); or Jang and Sheen Plant Cell 6: 1 665 (1994)), and (7) 
the vortexing method (see, e.g., Kindle supra). The method 
of transformation is not critical to the present invention. Any 
method Which provides for ef?cient transformation may be 
employed. As neWer methods are available to transform 
crops or other host cells, they may be directly applied. 
The following is an example outlining one particular 
technique, an Agrobacterium-mediated plant transforma 
tion. By this technique, the general process for manipulating 
genes to be transferred into the genome of plant cells is 
carried out in tWo phases. First, cloning and DNA modi? 
cation steps are carried out in E. coli, and the plasmid 
containing the gene construct of interest is transferred by 
conjugation or electroporation into Agrobacterium. Second, 
the resulting Agrobacterium strain is used to transform plant 
cells. Thus, for the generaliZed plant expression vector, the 
plasmid contains an origin of replication that alloWs it to 
replicate in Agrobacterium and a high copy number origin of 
replication functional in E. coli. This permits facile produc 
tion and testing of transgenes in E. coli prior to transfer to 
Agrobacterium for subsequent introduction into plants. 
Resistance genes can be carried on the vector, one for 
selection in bacteria, for example, streptomycin, and another 
that Will function in plants, for example, a gene encoding 
kanamycin resistance or herbicide resistance. Also present 
on the vector are restriction endonuclease sites for the 
addition of one or more transgenes and directional T-DNA 
border sequences Which, When recognized by the transfer 
functions of Agrobacterium, delimit the DNA region that 
Will be transferred to the plant. 
In another example, plant cells may be transformed by 
shooting into the cell tungsten microprojectiles on Which 
cloned DNA is precipitated. In the Biolistic Apparatus 
(Bio-Rad) used for the shooting, a gunpoWder charge (22 
caliber PoWer Piston Tool Charge) or an air-driven blast 
drives a plastic macroprojectile through a gun barrel. An 
aliquot of a suspension of tungsten particles on Which DNA 
has been precipitated is placed on the front of the plastic 
macroprojectile. The latter is ?red at an acrylic stopping 
plate that has a hole through it that is too small for the 
macroprojectile to pass through. As a result, the plastic 
macroprojectile smashes against the stopping plate, and the 
tungsten microprojectiles continue toWard their target 
through the hole in the plate. For the present invention, the 
target can be any plant cell, tissue, seed, or embryo. The 
DNA introduced into the cell on the microprojectiles 
becomes integrated into either the nucleus or the chloroplast. 
In general, transfer and expression of transgenes in plant 
cells are noW routine practices to those skilled in the art, and 
have become major tools to carry out gene expression 
studies in plants and to produce improved plant varieties of 
agricultural or commercial interest. 
Transgenic Plant Regeneration 
Plants cells transformed With plant expression vectors can 
be regenerated, for example, from single cells, callus tissue, 
or leaf discs according to standard plant tissue culture 
techniques. It is Well knoWn in the art that various cells, 
tissues, and organs from almost any plant can be success 
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fully cultured to regenerate an entire plant; such techniques 
are described, e.g., in Vasil supra; Green et al., supra; 
Weissbach and Weissbach, supra; and Gelvin et al., supra. 
In one particular example, a cloned chimeric synthase 
polypeptide under the control of the EAS4 promoter and the 
nopaline synthase terminator and carrying a selectable 
marker (for example, kanamycin resistance) is transformed 
into Agrobacterium. Transformation of leaf discs (for 
example, of tobacco leaf discs), With vector-containing 
Agrobacterium is carried out as described by Horsch et al. 
(Science 227:1229 (1985)). Putative transformants are 
selected after a feW Weeks (for example, 3 to 5 Weeks) on 
plant tissue culture media containing kanamycin (e.g., 100 
ug/ml). Kanamycin-resistant shoots are then placed on plant 
tissue culture media Without hormones for root initiation. 
Kanamycin-resistant plants are then selected for greenhouse 
groWth. If desired, seeds from self-fertilized transgenic 
plants can then be soWed in soil-less medium and groWn in 
a greenhouse. Kanamycin-resistant progeny are selected by 
soWing surfaced steriliZed seeds on hormone-free 
kanamycin-containing media. Analysis for the integration of 
the transgene is accomplished by standard techniques (see, 
for example, Ausubel et al. supra; Gelvin et al. supra). 
Transgenic plants expressing the selectable marker are 
then screened for transmission of the transgene DNA by 
standard immunoblot and DNA detection techniques. Each 
positive transgenic plant and its transgenic progeny are 
unique in comparison to other transgenic plants established 
With the same transgene. Integration of the transgene DNA 
into the plant genomic DNAis in most cases random, and the 
site of integration can profoundly effect the levels and the 
tissue and developmental patterns of transgene expression. 
Consequently, a number of transgenic lines are usually 
screened for each transgene to identify and select plants With 
the most appropriate expression pro?les. 
Transgenic lines are generally evaluated for levels of 
transgene expression. Expression at the RNA level is deter 
mined initially to identify and quantitate expression-positive 
plants. Standard techniques for RNA analysis are employed 
and include PCR ampli?cation assays using oligonucleotide 
primers designed to amplify only transgene RNA templates 
and solution hybridization assays using transgene-speci?c 
probes (see, e.g., Ausubel et al., supra). The RNA-positive 
plants are then analyZed for protein expression by Western 
immunoblot analysis using speci?c antibodies to the chi 
meric synthase (see, e.g., Ausubel et al., supra). In addition, 
in situ hybridiZation and immunocytochemistry according to 
standard protocols can be done using transgene-speci?c 
nucleotide probes and antibodies, respectively, to localiZe 
sites of expression Within transgenic tissue. 
Once the recombinant chimeric synthase protein is 
expressed in any cell or in a transgenic plant (for example, 
as described above), it may be isolated, e.g., using affinity 
chromatography. In one example, an anti-chimeric synthase 
antibody (e.g., produced as described in Ausubel et al., 
supra, or by any standard technique) may be attached to a 
column and used to isolate the polypeptide. Lysis and 
fractionation of chimeric synthase-producing cells prior to 
af?nity chromatography may be performed by standard 
methods (see, e.g., Ausubel et al., supra). Once isolated, the 
recombinant protein can, if desired, be further puri?ed, for 
example, by high performance liquid chromatography (see, 
e.g., Fisher, Laboratory Techniques In Biochemistry And 
Molecular Biology, eds., Work and Burdon, Elsevier, 1980). 
These general techniques of polypeptide expression and 
puri?cation can also be used to produce and isolate useful 
chimeric synthase fragments or analogs. Use 
The invention described herein is useful for a variety of 
agricultural, pharmaceutical, industrial, and commercial 
purposes. For example, the methods, DNA constructs, 
proteins, and transgenic organisms, including the bacteria, 




